Literature DB >> 22414938

Left ventricular systolic and diastolic function in obstructive sleep apnea: impact of continuous positive airway pressure therapy.

Mehmood Butt1, Girish Dwivedi, Alena Shantsila, Omer A Khair, Gregory Y H Lip.   

Abstract

BACKGROUND: Previous studies in obstructive sleep apnea (OSA) were limited by study cohorts with comorbidities that confound assessment of left ventricular (LV) systolic and diastolic function. We comprehensively evaluated LV function using 2-dimensional echocardiography (2DE), tissue Doppler imaging (TDI), and 3-dimensional echocardiography (3DE) in subjects moderate-severe OSA, who were compared with disease (patients with hypertension, no OSA) and healthy control subjects. METHODS AND
RESULTS: A total of 120 subjects (n=40 each of matched OSA, hypertension and healthy cohorts) underwent echocardiographic examination for the assessment of septal and posterior wall thickness, LV mass index, LV volumes and ejection fraction, mitral valve inflow indices (E, A), mitral annular velocity (S, E'), and left atrial volume index (LAVI). OSA subjects were treated with continuous positive airway pressure (mean duration of 26 weeks), after which the echocardiographic parameters were reassessed. Posterior wall thickness and LV mass index were significantly higher in OSA and hypertensive groups compared with healthy. Systolic S velocity was reduced in OSA and hypertensive compared with healthy control subjects (P<0.05). Diastolic function (E/A, IVRT, and E/E') was impaired in both OSA and hypertensive groups. On 3DE, mean LAVI was significantly greater in OSA and hypertensive compared with healthy. In OSA patients, continuous positive airway pressure therapy resulted in reduction of the posterior wall thickness (P=0.02) and improvement in LV ejection fraction (P<0.05), systolic S velocity (P<0.05), and diastolic LV impairment parameters.
CONCLUSIONS: Moderate to severe OSA causes structural and functional changes in V function and are comparable to that seen in hypertension. These abnormalities significantly improve after CPAP therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22414938     DOI: 10.1161/CIRCHEARTFAILURE.111.964106

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  24 in total

1.  Long term CPAP effects in myocardial performance in OSA. Always predictable and measurable cardiac index?

Authors:  Raquel Pérez Rojo; Antonio M Esquinas
Journal:  Sleep Breath       Date:  2015-01-08       Impact factor: 2.816

2.  [New therapy concepts for heart failure with preserved ejection fraction].

Authors:  C Tschöpe; B Pieske
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

3.  Decreased exercise capacity and sleep-disordered breathing in patients with hypertrophic cardiomyopathy.

Authors:  Tomas Konecny; Jeffrey B Geske; Ondrej Ludka; Marek Orban; Peter A Brady; Muaz M Abudiab; Felipe N Albuquerque; Alexander Placek; Tomas Kara; Karine R Sahakyan; Bernard J Gersh; A Jamil Tajik; Thomas G Allison; Steve R Ommen; Virend K Somers
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

4.  Pulmonary hypertension and echocardiogram parameters in obstructive sleep apnea.

Authors:  H T Wong; K H Chee; A W Chong
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-27       Impact factor: 2.503

5.  Relationship between diastolic ventricular dysfunction and subclinical sleep-disordered breathing in atrial fibrillation ablation candidates.

Authors:  Kazuaki Kaitani; Hirokazu Kondo; Koji Hanazawa; Naoaki Onishi; Yukiko Hayama; Akira Tsujimura; Maiko Kuroda; Shunsuke Nishimura; Yusuke Yoshikawa; Yusuke Takahashi; Masashi Amano; Sari Imamura; Yodo Tamaki; Soichiro Enomoto; Makoto Miyake; Toshihiro Tamura; Makoto Motooka; Chisato Izumi; Yoshihisa Nakagawa
Journal:  Heart Vessels       Date:  2015-07-01       Impact factor: 2.037

6.  Obstructive sleep apnea screening and postoperative mortality in a large surgical cohort.

Authors:  Ellen M Lockhart; Mark D Willingham; Arbi Ben Abdallah; Daniel L Helsten; Bahaa A Bedair; James Thomas; Stephen Duntley; Michael S Avidan
Journal:  Sleep Med       Date:  2013-03-13       Impact factor: 3.492

7.  Obesity and sleep apnea are independently associated with adverse left ventricular remodeling and clinical outcome in patients with atrial fibrillation and preserved ventricular function.

Authors:  Ravi V Shah; Siddique A Abbasi; Bobak Heydari; Hoshang Farhad; John A Dodson; Jessie P Bakker; Roy M John; Aristidis Veves; Atul Malhotra; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong; Tomas G Neilan
Journal:  Am Heart J       Date:  2014-01-15       Impact factor: 4.749

8.  Influence and predicting variables of obstructive sleep apnea on cardiac function and remodeling in patients without congestive heart failure.

Authors:  Yung-Lung Chen; Mao-Chang Su; Wen-Hao Liu; Chin-Chou Wang; Meng-Chih Lin; Mien-Cheng Chen
Journal:  J Clin Sleep Med       Date:  2014-01-15       Impact factor: 4.062

9.  Effects of Obstructive Sleep Apnea and Obesity on Cardiac Remodeling: The Wisconsin Sleep Cohort Study.

Authors:  Claudia E Korcarz; Paul E Peppard; Terry B Young; Carrie B Chapman; K Mae Hla; Jodi H Barnet; Erika Hagen; James H Stein
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

Review 10.  Continuous positive airway pressure and cardiovascular events in patients with obstructive sleep apnea.

Authors:  Athanasia Pataka; Renata L Riha
Journal:  Curr Cardiol Rep       Date:  2013-08       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.